Banyan Subsidiary Premier Medical Group Enters Joint Venture Agreement With PR Medical, Inc.
September 01 2010 - 9:30AM
Marketwired
Banyan Corporation (PINKSHEETS: BNYN) announced that its
subsidiary, Premier Medical Group, Inc. ("Premier"), has entered
into a Joint Venture Agreement (the "Agreement") with PR Medical,
Inc., ("PR Medical") a provider of TENS Units to health care
practitioners. The Agreement calls for Premier to provide
operational management and support for PR Medical as well as
directing the sales force.
"TENS" is the acronym for Transcutaneous
Electrical Nerve
Stimulation. A "TENS Unit" is a pocket size,
portable, battery-operated device that sends electrical impulses to
certain parts of the body to block pain signals. TENS Units should
only be used under the direction of a physician. Electrodes are
attached to the surface of the skin over or near the area where the
patient is experiencing pain. TENS are an agreeable alternative to
pharmaceuticals or other kinds of pain relief management.
Premier's head of sales, Glen Collins, stated: "As we currently
provide medical diagnostic services, we have a complete
infrastructure that allows us to take over management and
operational support for PR Medical. The PR Medical product is
complementary to our own business and we feel we will be able to
utilize our current sales operations to increase PR Medical
sales."
The Joint Venture calls for Premier to share profits equally
with PR Medical.
About Banyan Corporation:
Banyan Corporation is a publicly traded holding company focused
on investing in and building a network of operating subsidiaries
engaged in various innovative businesses. Currently the company's
subsidiaries, Premier Medical Group, Inc. and affiliated companies,
provide diagnostic testing services to physicians nationwide.
This Press Release contains or incorporates by reference forward
looking statements including certain information with respect to
plans and strategies of Banyan Corporation. For this purpose, any
statements contained herein or incorporated herein by references
that are not statements of historical fact may be deemed forward
looking statements. Without limiting the foregoing, the words
"believes," "suggests," "anticipates," "plans," "expects," and
similar expressions are intended to identify forward looking
statements. There are a number of events or actual results of
Banyan Corporation operations that could differ materially from
those indicated by such forward looking statements.
Contact: Investor Relations Michael Gelmon 1-310-909-4607
www.PMGtesting.com
Banyan (CE) (USOTC:BNYN)
Historical Stock Chart
From Dec 2024 to Jan 2025
Banyan (CE) (USOTC:BNYN)
Historical Stock Chart
From Jan 2024 to Jan 2025